Clearmind Medicine Inc Common Shares
Price & Volume
Stats
See moreOpen | $0.19 |
Previous Close | $0.19 |
Day Range | $0.17-$0.19 |
52W Range | $0.17-$2.18 |
Market Cap | $1.1M |
Shares Short | 257,653 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.75 |
News
See moreYahoo Finance • 3 hours ago
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
Yahoo Finance • yesterday
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
Yahoo Finance • 7 days ago
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Yahoo Finance • 8 days ago
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
About
Address | 1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
